SCHEMBL6963244

SCHEMBL6963244

OCCCc1cc(N2CCCCC2)ccn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 5/20 0.46
LNPEP Q9UIQ6 2/20 0.46
ELOVL1 Q9BW60 1/20 0.45
CHKA P35790 2/20 0.41
MAP4K4 O95819 1/20 0.38
TERT O14746 3/20 0.38
IP6K1 Q92551 2/20 0.37
USP30 Q70CQ3 1/20 0.37
CXCR4 P61073 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
S100B P04271 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6958116 0.85 HRH4 (0.46) HRH4LNPEPELOVL1CHKAMAP4K4
SCHEMBL19996086 0.84 HRH4 (0.50) HRH4LNPEPELOVL1CHKAMAP4K4
SCHEMBL28585221 0.76 HRH4 (0.47) HRH4LNPEPELOVL1CHKAMAP4K4
SCHEMBL19518769 0.75 HRH4 (0.61) HRH4MAPTMAPK1HTT
Water SCHEMBL28114124 0.74 HRH4 (0.50) HRH4LNPEPELOVL1CHKATERT
Hydrochloric Acid SCHEMBL10496813 0.72 ACHE (0.48) HRH4LNPEPELOVL1ALDH1A1MAPT
SCHEMBL21456184 0.71 OPRM1 (0.46)
SCHEMBL31342593 0.70 ELOVL1 (0.46) HRH4LNPEPELOVL1ALDH1A1MAPT
SCHEMBL23205339 0.70 OPRM1 (0.47) CXCR4
SCHEMBL29380102 0.69 CDK1 (0.45) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed